Pergi ke luar talian dengan aplikasi Player FM !
7/28/2022 - COVID-19 Immunity Interview Part 1
Manage episode 335792236 series 2065653
Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 immunity. Topics: *Is COVID-19 here to stay? *Immunity evasiveness of Omicron BA.4 and BA.5 *Expectations for the fall and winter 2022 *Thoughts on upcoming booster reformulation *Should you get a booster now or wait?
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-28-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Michael Mina, MD, PhD, Chief Science Officer, eMed, Epidemiologist, Immunologist and Physician
Hosted on Acast. See acast.com/privacy for more information.
216 episod
Manage episode 335792236 series 2065653
Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 immunity. Topics: *Is COVID-19 here to stay? *Immunity evasiveness of Omicron BA.4 and BA.5 *Expectations for the fall and winter 2022 *Thoughts on upcoming booster reformulation *Should you get a booster now or wait?
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-28-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Michael Mina, MD, PhD, Chief Science Officer, eMed, Epidemiologist, Immunologist and Physician
Hosted on Acast. See acast.com/privacy for more information.
216 episod
所有剧集
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.